Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis

References

• Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med. 1999;341(16):1284–91.
   PubMedGoogle Scholar
• Zouboulis CC, May T. Pathogenesis of adamantiades-behcet's disease. Med Microbiol Immunol. 2003;192(3):149–55.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med. 2009;360(23): 2467–70.
   PubMed Web of Science ®Google Scholar
• Gul A. Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy. 2005;4(1):81–3.
   PubMedGoogle Scholar
• Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20(9):1544–49.
   PubMed Web of Science ®Google Scholar
• Gul A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A, et al. Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis. 2012;71(4):563–6.
   PubMed Web of Science ®Google Scholar
• Deal watch: XOMA and Servier to develop anti-IL-1beta antibody for inflammatory diseases. Nat Rev Drug Discov. 2011;10(3):166.
   Web of Science ®Google Scholar
• Botsios C, Sfriso P, Furlan A, Punzi L, Dinarello CA. Resistant Behcet disease responsive to anakinra. Ann Intern Med. 2008; 149(4):284–6.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
   PubMed Web of Science ®Google Scholar
• Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335(8697):1078–80.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Zhang Junming LZ, Tonghua X. Interleukin 1 receptor antagonist gene polymorphism and Behcet's syndrome. Chinese J Dermatovenereol. 1997;11(4):197–8.
   Google Scholar
• Liu Xiang-dong SS-h, Dong-jie X, Guo-ying M, Yun-shan W. Association of il-1 receptor antagonist gene 2/2 genotype with increased susceptibility for Bechcet's disease with uveitis. J Shandong University (Health Sciences). 2007;45(5):467–9.
   Google Scholar
• Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford). 2003;42(7):8604.
   Web of Science ®Google Scholar
• Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O. Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease. Exp Dermatol. 2005;14(2):124–9.
   PubMed Web of Science ®Google Scholar
• Alayli G, Aydin F, Coban AY, Sullu Y, Canturk F, Bek Y, et al.T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin Rheumatol. 2007;26(8):1299–305.
   PubMed Web of Science ®Google Scholar
• Akman A, Ekinci NC, Kacaroglu H, Yavuzer U, Alpsoy E, Yegin O. Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behcet's disease. Arch Dermatol Res. 2008;300(1):19–26.
   PubMed Web of Science ®Google Scholar
• Ozcimen AA, Dilek K, Bingol U, Saricaoglu H, Sarandol A, Taskapilioglu O, et al. Oral, IL-1 cluster gene polymorphisms in Turkish patients with Behcet's disease. Int J Immunogenet. 2011;38(4):295–301.
   PubMed Web of Science ®Google Scholar
• Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res. 2000;79(11):1864–9.
   PubMed Web of Science ®Google Scholar
• Hulkkonen J. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw. 2000;11(2):251–5.
   PubMed Web of Science ®Google Scholar
• McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995;38(2): 221–8.
   PubMedGoogle Scholar
• Hutyrova B, Lukac J, Bosak V, Buc M, du Bois R, Petrek M. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. J Rheumatol. 2004;31(1):81–4.
   PubMed Web of Science ®Google Scholar
• Nemetz A, Nosti-Escanilla MP, Molnar T, Kope A, Kovacs A, Feher J, et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics. 1999;49(6):527–31.
   PubMed Web of Science ®Google Scholar
• Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992;22(6): 396–402.
   PubMed Web of Science ®Google Scholar
• Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47(3):195–8.
   PubMed Web of Science ®Google Scholar
• Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25(1):222–7.
   PubMed Web of Science ®Google Scholar
• Sarial S, Shokrgozar MA, Amirzargar A, Shokri F, Radfar J, Zohrevand P, et al. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol. 2008;7(1):37–40.
   PubMed Web of Science ®Google Scholar
• Banu C, Moise A, Arion C, Coriu D, Tanase A. Constantinescu I, Cytokine gene polymorphisms support diagnostic monitoring of Romanian multiple myeloma patients. J Med Life. 2011;4(3): 264–8.
   PubMedGoogle Scholar
• Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995;99(2):303–10.
   PubMed Web of Science ®Google Scholar
• Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 1994;106(3):637–42.
   PubMed Web of Science ®Google Scholar
• Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 1994;37(9):1380–5.
   PubMedGoogle Scholar
• Tarlow JK, Clay FE, Cork MJ, Blakemore AI, McDonagh AJ, Messenger AG, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol. 1994;103(3):387–90.
   PubMed Web of Science ®Google Scholar
• Clay FE, Cork MJ, Tarlow JK, Blakemore AI, Harrington CI, Lewis F, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet. 1994;94(4):407–10.
   PubMed Web of Science ®Google Scholar